Synthesis and cytotoxicity screening of piperazine-1-carbodithioate derivatives of 2-substituted quinazolin-4(3H)-ones

Archiv der Pharmazie

Volumn 342, Issue 3, 2009, Pages 182-189

  Cao, Sheng Li ^a   Guo, Yan Wen ^b   Wang, Xian Bo ^b   Zhang, Mei ^a   Feng, Yu Ping ^c,d   Jiang, Yu Yang ^c,d,e   Wang, Yue ^c,d,e   Gao, Qian ^a   Ren, Jian ^a  

^a CAPITAL NORMAL UNIVERSITY   (China)

^b BEIJING INSTITUTE OF TECHNOLOGY   (China)

^c BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^d TSINGHUA UNIVERSITY   (China)

^e Key Laboratory of Chemical Biology   (China)

Author keywords

Cytotoxicity; Dithiocarbamate; Quinazolin 4(3H) one; Screening; Synthesis

Indexed keywords

PIPERAZINE DERIVATIVE; QUINAZOLINONE DERIVATIVE;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG SCREENING; DRUG SYNTHESIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL SURVIVAL; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; QUINAZOLINONES;

EID: 62549131192     PISSN: 03656233     EISSN: 15214184     Source Type: Journal    
DOI: 10.1002/ardp.200800148     Document Type: Article

References (22)

1. I. M. Kompis, K. Islam, R. L. Then, Chem. Rev. 2005, 105, 593-620.
2. D. Cunningham, J. Zalcberg, J. Maroun, R. James, et al., Eur. J. Cancer 2002, 38, 478-486.
3. K. Pawelczak, M. Makowski, M. Kempny, J. M. Dzik, et al., Acta Biochim. Pol. 2002,49, 407-420.
4. C.-G. Cheong, D. W. Wolan, S. E. Greasley, P. A. Horton, et al., J. Biol. Chem. 2004, 279,18034-18045.
5. S. T. Al-Rashood, I. A. Aboldahab, M. N. Nagi, L. A. Abou- zeid, et al., Bioorg. Med. Chem. 2006, 14, 8608-8621.
6. E. Chu, M. A. Callender, M. P. Farrell, J. C. Schmitz, Cancer Chemother. Pharmacol. 2003, 52, S80-S89.
7. A. Gangjee, H. D. Jain, J. Phan, R. L. Kisliuk, J. Heterocycl. Chem. 2005, 42, 165-168.
8. A. Gangjee, H. D. Jain, R. L. Kisliuk, Bioorg. Med. Chem. Lett. 2005, 15, 2225-2230.
9. C. Gerhauser, M. You, J. Liu, R. M. Moriarty, et al., Cancer Res. 1997, 57, 272-278.
10. M. Sabol, P. Kutschy, L. Siegfried, A. Mirossay, et al, Biologia 2000, 55, 701 -707.
11. A. Scozzafava, A. Mastrolorenzo, C. T. Supuran, Bioorg. Med. Chem. Lett. 2000, 10, 1887-1891.
12. M. Pilatova, M. Sarissky, P. Kutschy, A. Mirossay, et al., Leuk. Res. 2005, 29, 415-421.
13. O. Guzel, A. Salman, Bioorg.Med.Chem. 2006, 14, 7804-7815.
14. P. Gaspari, T. Banerjee, W. P. Malachowski, A. J. Muller, et al., J. Med. Chem. 2006, 49, 684-692.
15. F. Liu, S. Y. Liu, Y. Liu, D. X. Han, et al., Chin. Sci. Bull. 2007, 52, 3200-3206.
16. S. L. Cao, Y. P. Feng, Y. Y. Jiang, S. Y. Liu, et al., Bioorg. Med. Chem. Lett. 2005, 15, 1915-1917.
17. S. L. Cao, Y. Y. Jiang, Y. P. Feng, S. Y. Liu, et al., Yaoxue Xuebao 2007, 42, 741-746.
18. P. R. Marsham, P. Chambers, A. J. Hayter, L. R. Hughes, et al., J. Med. Chem. 1989, 32, 569-575.
19. L. R. Hughes, A. L. Jackman, J. Oldfield, R. C. Smith, et al., J. Med. Chem. 1990, 33, 3060-3067.
20. S. L. Cao, Y. P. Feng, H. H. Gao, K. R. Feng, Yingyong Huaxue 2005, 22, 1027-1029.
21. S. L. Cao, Y. P. Feng, X. L. Zheng, Y. Y. Jiang, et al., Arch. Pharm. Chem. Life Sci. 2006, 339, 250-254.
22. S. L. Cao, X. Q. Ma, Huaxue Shiji 2004, 26, 27-28.